Ice Cold-PCR Precipio Inks Distribution Deal With Italy's Euroclone Diagnostica Euroclone will sell Precipio's Ice Cold-PCR DNA enrichment products for use with liquid biopsies exclusively in Italy and non-exclusively in the rest of Europe. Core Diagnostics to Offer Precipio's Liquid Biopsy Tests in India The lab, which serves hospitals in India and surrounding countries, will use Precipio's ICE COLD-PCR technology to offer blood-based mutation tests. Transgenomic Shareholders Approve Merger With Precipio Dx More than 90 percent of voting Transgenomic shareholders gave the go-ahead to the deal. Upon completion of the merger, the new firm will take on the Precipio name. Transgenomic Delisted from Nasdaq The firm said that its shares will begin trading on the OTCQB exchange starting on Feb. 22. Transgenomic, Precipio Diagnostics Ink Merger Agreement Under the agreement, Precipio would become a wholly owned subsidiary of Transgenomic, which would then adopt the new name Precipio. Sep 29, 2016 Transgenomic Gains Distributors in China, India for ICEme Kits Sep 22, 2016 Transgenomic to Share Melbourne Research Data With Ventana Medical Systems Aug 15, 2016 Transgenomic Q2 Revenues Edge Up as Net Loss Narrows Mar 8, 2016 At Tri-Con, Researchers Present Novel PCR Approaches to Liquid Biopsy Dec 23, 2015 Transgenomic, Dana-Farber Win $1.5M NIH Grant to Improve ICE COLD-PCR Nov 12, 2015 Transgenomic Q3 Revenues Slip 3 Percent on Lower Lab Services Sales Sep 17, 2015 Transgenomic Licenses Liquid Biopsy Tech to University of Melbourne Aug 27, 2015 Transgenomic Inks Distribution Deals for China, Japan Aug 13, 2015 Transgenomic Q2 Revenues Climb 4 Percent Jul 1, 2015 Transgenomic Aims to Widely License PCR Tech While Prepping Cancer Test Kits for Market Premium May 14, 2015 Transgenomic Q1 Revenues Grow 4 Percent Apr 23, 2015 Transgenomic, Horizon Discovery Sign OEM Pact Apr 16, 2015 Transgenomic Q4 Revenues Up 24 Percent Mar 11, 2015 Transgenomic Expands License Agreement With Exiqon Mar 4, 2015 Transgenomic Closes Public Offering of Stock, Warrants Oct 22, 2014 Transgenomic Raises $2.4M in Private Placement Aug 6, 2014 Transgenomic Q2 Revenues Drop 7 Percent May 28, 2014 Transgenomic, Dana-Farber Expand ICE COLD-PCR License May 7, 2014 Transgenomic Q1 Revenues Slide 15 Percent May 6, 2014 Transgenomic Shares Moving to Nasdaq Load More Breaking News Compact Gene Editing Enzyme May Improve Success Rates of Gene Therapies People in the News at Veracyte, Invitae, Mount Sinai, InterVenn Biosciences, Applied BioCode, More New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More FDA Releases Proposed Rule for Oversight of Laboratory-Developed Tests CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.